Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Cash from Investing Activities: 2010-2025

Historic Cash from Investing Activities for Vanda Pharmaceuticals (VNDA) over the last 15 years, with Sep 2025 value amounting to $21.4 million.

  • Vanda Pharmaceuticals' Cash from Investing Activities rose 77.18% to $21.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.0 million, marking a year-over-year increase of 182.79%. This contributed to the annual value of -$17.4 million for FY2024, which is 44.58% down from last year.
  • Vanda Pharmaceuticals' Cash from Investing Activities amounted to $21.4 million in Q3 2025, which was up 239.90% from -$15.3 million recorded in Q2 2025.
  • Over the past 5 years, Vanda Pharmaceuticals' Cash from Investing Activities peaked at $187.3 million during Q1 2023, and registered a low of -$190.9 million during Q2 2023.
  • For the 3-year period, Vanda Pharmaceuticals' Cash from Investing Activities averaged around $1.9 million, with its median value being $4.0 million (2024).
  • Per our database at Business Quant, Vanda Pharmaceuticals' Cash from Investing Activities crashed by 1,351.13% in 2021 and then skyrocketed by 15,204.23% in 2022.
  • Over the past 5 years, Vanda Pharmaceuticals' Cash from Investing Activities (Quarterly) stood at -$26.0 million in 2021, then spiked by 390.13% to $75.4 million in 2022, then crashed by 158.05% to -$43.8 million in 2023, then soared by 109.12% to $4.0 million in 2024, then surged by 77.18% to $21.4 million in 2025.
  • Its last three reported values are $21.4 million in Q3 2025, -$15.3 million for Q2 2025, and $43.9 million during Q1 2025.